(Q37264376)

19 August 2017

1 reference

title

Anti-heart autoantibodies in familial dilated cardiomyopathy (English)

1 reference

19 August 2017

1 reference

3

Sabino Iliceto

1 reference

19 August 2017

Alida L P Caforio

1

1 reference

19 August 2017

Annalisa Vinci

series ordinal

2

1 reference

19 August 2017

publication date

1 September 2008

1 reference

19 August 2017

1 reference

19 August 2017

volume

41

1 reference

19 August 2017

issue

6

1 reference

19 August 2017

page(s)

462-469

1 reference

Genetics of dilated cardiomyopathy

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F08916930802031546

Dilated cardiomyopathy: learning to live with yourself.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802031546

Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802031546

Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802031546

Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802031546

Recognition and optimum management of myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802031546

Inflammation, ECG changes and pericardial effusion: whom to biopsy in suspected myocarditis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802031546

Myocarditis: current trends in diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802031546

A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802031546

Pathogenesis of chronic Chagas heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802031546

Connecting the missing link between dilated cardiomyopathy and viral myocarditis: virus, cytoskeleton, and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802031546

Defining criteria for autoimmune diseases (Witebsky's postulates revisited)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802031546

Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802031546

Tackling medical futility in Texas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802031546

Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802031546

Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802031546

Clinical and immunologic characteristics in peripartum cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802031546

Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802031546

Myocarditis in hypertrophic cardiomyopathy patients presenting acute clinical deterioration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802031546

Cardiac histological substrate in patients with clinical phenotype of Brugada syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802031546

Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802031546

Echocardiographic evaluation in asymptomatic relatives of patients with dilated cardiomyopathy reveals preclinical disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802031546

Autoimmune studies in patients with primary myocardial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802031546

Immunologic findings in idiopathic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802031546

Organ-specific cardiac antibodies: serological markers for systemic hypertension in autoimmune polyendocrinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802031546

Autoimmunity to alpha myosin in a subset of patients with idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802031546

Circulating heart autoantibodies in familial as compared with nonfamilial idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802031546

Antibodies against stress proteins in sera of patients with dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802031546

Complement-mediated cytotoxic activity of anti-heart antibodies present in the sera of patients with dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802031546

Autoantibodies produced against sarcolemmal Na-K-ATPase: possible upstream targets of arrhythmias and sudden death in patients with dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802031546

Immunological analysis of auto-antibodies against the adenine nucleotide translocator in dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802031546

Antibody-mediated enhancement of calcium permeability in cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802031546

Beta-adrenoceptor antibodies and genetics in dilated cardiomyopathy-- An overview and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802031546

Autoantibodies activating human beta1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802031546

Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802031546

Abnormal cytokine profiles in patients with idiopathic dilated cardiomyopathy and their asymptomatic relatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802031546

Immunoglobulin isotype determines pathogenicity in antibody-mediated myocarditis in naïve mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802031546

Autoimmune cardiomyopathy and heart block develop spontaneously in HLA-DQ8 transgenic IAbeta knockout NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802031546

A spontaneous model for autoimmune myocarditis using the human MHC molecule HLA-DQ8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802031546

Spontaneous myocarditis mimicking human disease occurs in the presence of an appropriate MHC and non-MHC background in transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802031546

Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802031546

Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802031546

Genetic modification of risk assessment based on staging of preclinical type 1 diabetes in siblings of affected children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802031546

Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802031546

beta(1)-Adrenergic receptor function, autoimmunity, and pathogenesis of dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802031546

Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802031546

Reviews of translational medicine and genomics in cardiovascular disease: new disease taxonomy and therapeutic implications cardiomyopathies: therapeutics based on molecular phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802031546

Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930802031546

10.1080/08916930802031546

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference